Zhende Medical Co., Ltd. (SHA:603301)
China · Delayed Price · Currency is CNY 91.00
+1.74 (1.95%)
Jul 31, 2026, 3:00 PM CST
Zhende Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 264.02 | 260.82 | 385.17 | 198.4 | 679.88 | 595.86 |
Depreciation & Amortization | 292.65 | 292.65 | 246.52 | 242.97 | 194.28 | 139.3 |
Other Amortization | 6.18 | 6.18 | 1.27 | 1.33 | 1.05 | 3.76 |
Loss (Gain) From Sale of Assets | -0.64 | -0.64 | -93.43 | 15.96 | 13.53 | 0.61 |
Asset Writedown & Restructuring Costs | -1.8 | -1.8 | 9.09 | 54.32 | 8.88 | 3.31 |
Loss (Gain) From Sale of Investments | -10.78 | -10.78 | -7.37 | -12.42 | 60.17 | -34.03 |
Provision & Write-off of Bad Debts | 13.11 | 13.11 | 10.23 | 1.8 | 8.6 | 1.44 |
Other Operating Activities | 110.12 | 79.81 | 61.66 | 214.65 | 116.03 | 198.18 |
Change in Accounts Receivable | -112.17 | -112.17 | -255.37 | 307.45 | -127.95 | 49.71 |
Change in Inventory | 1.55 | 1.55 | -10.44 | -12.7 | -228.71 | 279.07 |
Change in Accounts Payable | 11.63 | 11.63 | 100.42 | -536.27 | 507.89 | -426.96 |
Change in Other Net Operating Assets | - | - | - | 5.22 | 17.34 | 23.6 |
Operating Cash Flow | 572.01 | 538.49 | 461.14 | 452.11 | 1,246 | 817.63 |
Operating Cash Flow Growth | 40.52% | 16.77% | 2.00% | -63.72% | 52.40% | -73.80% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -431.33 | -550.22 | -769.69 | -599.24 | -754.12 | -695.47 |
Sale of Property, Plant & Equipment | 67.67 | 67.53 | 121.59 | 12.61 | 9.58 | 6.78 |
Cash Acquisitions | -301.05 | -301.05 | -48.66 | -311.91 | -77.09 | -545.54 |
Divestitures | - | - | - | - | 51.57 | - |
Investment in Securities | -114.76 | -20.2 | -74.85 | -159.25 | -216.68 | 674.44 |
Other Investing Activities | 2.86 | 6.31 | 3.62 | -0.07 | -6.05 | 5.36 |
Investing Cash Flow | -776.61 | -797.64 | -767.99 | -1,058 | -992.79 | -554.42 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | 20.28 | 41.55 | - |
Long-Term Debt Issued | - | 1,637 | 1,419 | 916.9 | 1,839 | 885 |
Total Debt Issued | 1,002 | 1,637 | 1,419 | 937.18 | 1,880 | 885 |
Short-Term Debt Repaid | - | -15.69 | -28.35 | -16.38 | - | - |
Long-Term Debt Repaid | - | -960.18 | -1,400 | -920.36 | -1,992 | -541.26 |
Total Debt Repaid | -881.87 | -975.87 | -1,428 | -936.74 | -1,992 | -541.26 |
Net Debt Issued (Repaid) | 119.63 | 660.63 | -9.08 | 0.43 | -112.05 | 343.74 |
Issuance of Common Stock | 0.7 | 0.7 | - | - | 1,018 | 52.5 |
Repurchase of Common Stock | -15.49 | -15.49 | - | - | -113.15 | -133.38 |
Common Dividends Paid | -204.15 | -201.49 | -159.4 | -423.72 | -164.25 | -543.65 |
Other Financing Activities | -0.13 | - | -0.95 | - | -172.96 | -98.77 |
Financing Cash Flow | -99.44 | 444.34 | -169.43 | -423.28 | 456 | -379.57 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -23.55 | -13.54 | 21.2 | 12.81 | -3.7 | -38.29 |
Net Cash Flow | -327.59 | 171.66 | -455.07 | -1,016 | 705.55 | -154.65 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 140.68 | -11.73 | -308.55 | -147.13 | 491.92 | 122.16 |
Free Cash Flow Growth | - | - | - | - | 302.68% | -93.98% |
Free Cash Flow Margin | 3.24% | -0.27% | -7.24% | -3.56% | 8.02% | 2.40% |
Free Cash Flow Per Share | 0.53 | -0.04 | -1.16 | -0.55 | 2.08 | 0.54 |
Levered Free Cash Flow | 42.32 | 65.1 | -532.76 | -338.45 | 226.69 | -336.72 |
Unlevered Free Cash Flow | 63.71 | 84.78 | -514.8 | -320.37 | 247.65 | -321.05 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 103.54 | 165.91 | 76.7 | 164.58 | 38.26 | 475.64 |
Change in Working Capital | -100.86 | -100.86 | -152 | -264.91 | 163.63 | -90.81 |